F.D.A. Deal Would Relax Rules on Reporting Medical Device Problems
The makers of cardiac defibrillators, insulin pumps, breast implants and other devices will be able to delay the reporting of malfunctions under an agreement headed to Congress.
Source: NYT Health - Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Medical Devices United States Politics and Government Food and Drug Administration Defective Products Source Type: news
More News: Breast Augmentation | Food and Drug Administration (FDA) | Government | Health | Insulin | Medical Devices | Plastic Surgery | Politics | USA Health